Company profile
Monte Rosa Therapeutics, Inc. insider acquisitions
Company CIK 0001826457 · Reported insider acquisitions and filing context.
These are company listings. A transaction is linked to a particular security only when the filing provides enough information.
Company activity summary
By transaction date, as of October 23, 2026.
No records are loaded for this 30-day transaction window. This does not establish that no transactions occurred.
Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.
Transaction timeline
Who reported an acquisition, and when the transaction occurred.
10 dated transactions · 5 of 5 reporting owners shown. Select one owner to focus the chart.
View timeline as a table
| Transaction date | Company / security | Reporting owners | Acquisition type |
|---|---|---|---|
| Jan 2, 2026 | Monte Rosa Therapeutics, Inc.Stock Option (Right to Buy) | Nickson Philip | Stock award |
| Jan 2, 2026 | Monte Rosa Therapeutics, Inc.Common Stock | Nickson Philip | Stock award |
| Jan 2, 2026 | Monte Rosa Therapeutics, Inc.Stock Option (Right to Buy) | Champoux Jennifer | Stock award |
| Jan 2, 2026 | Monte Rosa Therapeutics, Inc.Common Stock | Champoux Jennifer | Stock award |
| Jan 2, 2026 | Monte Rosa Therapeutics, Inc.Stock Option (Right to Buy) | Warmuth Markus | Stock award |
| Jan 2, 2026 | Monte Rosa Therapeutics, Inc.Common Stock | Warmuth Markus | Stock award |
| Jan 2, 2026 | Monte Rosa Therapeutics, Inc.Stock Option (Right to Buy) | Janku Filip | Stock award |
| Jan 2, 2026 | Monte Rosa Therapeutics, Inc.Common Stock | Janku Filip | Stock award |
| Jan 2, 2026 | Monte Rosa Therapeutics, Inc.Stock Option (Right to Buy) | Townson Sharon | Stock award |
| Jan 2, 2026 | Monte Rosa Therapeutics, Inc.Common Stock | Townson Sharon | Stock award |
Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.
Share price & reported acquisitions
Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.
Price history is not available
Market-price history is not connected yet.
GLUE · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.
Reported acquisitions
Filing-date filters apply to the list and timeline. The summary above uses transaction dates.
| Filed / transacted | Reporting owners | Type / security | Quantity | Price / reference value | Details |
|---|---|---|---|---|---|
| Trade: | Nickson PhilipChief Business & Legal Officer | Stock awardStock Option (Right to Buy)Derivative security · Code A | 126,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Nickson PhilipChief Business & Legal Officer | Stock awardCommon StockNon-derivative security · Code A | 28,000 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Champoux JenniferChief Operating Officer | Stock awardStock Option (Right to Buy)Derivative security · Code A | 158,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Champoux JenniferChief Operating Officer | Stock awardCommon StockNon-derivative security · Code A | 35,000 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Warmuth MarkusPresident & CEO · Director | Stock awardStock Option (Right to Buy)Derivative security · Code A | 406,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Warmuth MarkusPresident & CEO · Director | Stock awardCommon StockNon-derivative security · Code A | 90,000 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Janku FilipChief Medical Officer | Stock awardStock Option (Right to Buy)Derivative security · Code A | 139,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Janku FilipChief Medical Officer | Stock awardCommon StockNon-derivative security · Code A | 31,000 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
| Trade: | Townson SharonChief Scientific Officer | Stock awardStock Option (Right to Buy)Derivative security · Code A | 158,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Townson SharonChief Scientific Officer | Stock awardCommon StockNon-derivative security · Code A | 35,000 | Not reported *Value: Not reportedCurrency not specified | View ↗ |
10 transactions on this page. Filing date, newest first.
Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →